Вопросы современной педиатрии (Mar 2009)
QUALITY OF LIFE IN ADOLESCENTS WITH MULTIPLE SCLEROSIS TREATED WITH INTERFERON BETA-1A FOR SUBCUTANEOUS INJECTION
Abstract
This article presents results of a trial, studying quality of life of adolescents with multiple sclerosis. Obtained data show, that adolescents had decreased quality of life, including physical and psychosocial functioning. Decreasing of total rate of quality of life was concerned with, first of all, disorders in school and physical functioning, and emotional constituent was intact. It was shown, that pathogenetic treatment with interferon beta1? (Rebif) did not significantly decreased psycho-emotional constituent of quality of life. On the contrary, patient in remission had increase of rates of psycho-social health on the basis of insignificant decrease of physical and emotional indices, ant that caused increase of summary rate of quality of life.Key words: adolescents, multiple sclerosis, quality of life.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(2):99-103)